Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
18.54
-0.10 (-0.54%)
Sep 5, 2025, 2:56 PM - Market open
Viridian Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Viridian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $38.8, which forecasts a 109.28% increase in the stock price over the next year. The lowest target is $26 and the highest is $61.
Price Target: $38.8 (+109.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 6 | 6 | 6 | 5 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +61.81% | Aug 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +121.14% | Aug 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +40.24% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | +72.60% | Aug 7, 2025 |
| Needham | Needham | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +83.39% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
145.10K
from 302.00K
Decreased by -51.96%
Revenue Next Year
51.06M
from 145.10K
Increased by 35,092.80%
EPS This Year
-3.90
from -3.07
EPS Next Year
-4.21
from -3.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 315,000 | 130.6M | |||
| Avg | 145,095 | 51.1M | |||
| Low | n/a | 14.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.3% | 89,923.8% | |||
| Avg | -52.0% | 35,092.8% | |||
| Low | - | 10,092.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.97 | -3.05 | |||
| Avg | -3.90 | -4.21 | |||
| Low | -4.35 | -5.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.